Quantification of siderophages in bronchoalveolar fluid in transfusional and primary pulmonary hemosiderosis.
Transfusional iron overload may occur in the lungs. We hypothesized that quantitating siderophages in the bronchoalveolar fluid (BALF) of heavily transfused patients may prove to be a useful tool in determining lung iron overload in transfusion-dependent patients. The study included six patients (7-20 years) with thalassemia major (TM) who had received multiple blood transfusions, one with hereditary spherocytosis (four blood transfusions) and one with sickle cell disease (never transfused); they were compared to three children with idiopathic pulmonary hemosiderosis (IPH) (2.5-7.0 years) as positive controls. Fiberoptic bronchoscopy with bronchoalveolar lavage was performed in seven patients under general anesthesia for elective surgery and the rest were bronchoscoped electively under sedation. Spirometry was also performed in eight patients. There was no significant difference between children with TM and IPH in siderophages as percentage of total count (95% CI -31.0 to 1.5, P = 0.068). There were positive relationships between both mean serum ferritin values during the preceding year and the total number of units of transfused blood, and percent siderophage count among multiply transfused patients (P = 0.010, P = 0.052, respectively); similar findings were noted for the Golde score (P = 0.001, P = 0.031, respectively). None of the patients showed lung function impairment. In conclusion, in this small study, we found that the BALF of multiply transfused patients with benign hematological disorders contain similar numbers of siderophages to that of patients with IPH; this is strongly suggestive of secondary pulmonary hemosiderosis. The correlation between the patients' serum ferritin, and the BALF siderophages suggests that the later may serve as a marker of pulmonary iron overload in patients requiring blood transfusion and appear to be more sensitive than standard pulmonary function tests.
Priftis
Kostas N
KN
Department of Allergy-Pneumonology, Penteli Children's Hospital, P. Penteli, Greece. kpriftis@otenet.gr
Anthracopoulos
Michael B
MB
Tsakanika
Constantina
C
Tapaki
Georgia
G
Ladis
Vassilis
V
Bush
Andrew
A
Nicolaidou
Polyxeni
P
D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000032:analysis; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology*; D001999:Bronchoscopy; D002648:Child; D002675:Child, Preschool; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D005260:Female; D005293:Ferritins / Q000097:blood; D006485:Hemosiderin / Q000032:analysis*; D006486:Hemosiderosis / Q000175:diagnosis / Q000209:etiology / Q000473:pathology*; D006801:Humans; D016014:Linear Models; D016676:Macrophages, Alveolar / Q000737:chemistry* / Q000378:metabolism; D008297:Male; D015999:Multivariate Analysis; D012129:Respiratory Function Tests; D017086:beta-Thalassemia / Q000473:pathology* / Q000503:physiopathology
D015415:Biomarkers; D005293:Ferritins; D006485:Hemosiderin